Methods: The study included 18 CAH patients with complete characterization of CYP21A2 mutations and were sorted based on the severity of the inherited mutations and the expected percentage of 21-hydroxylase enzyme activity. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.